Inventor
BING YANG
Inventor
CN
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G01Nprimary
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
A61KPreparations for medical, dental or toiletry purposes5%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations5%
C07KPeptides5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
G06TImage data processing or generation, in general5%
C08LCompositions of macromolecular compounds4%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data4%
H04LTransmission of digital information, e.g. telegraphic communication4%
H04WWireless communication networks4%
PatentTitleYear
12,493,045Multi-target crosslinkers and uses thereof202512,464,544Communication method, apparatus, and system202512,362,535Optical element, optical element monitoring system and method, active light emitting module, and terminal202512,322,080Dual-neighborhood wear angle automatic detection method2025D1073643Audio202512,252,747Unbiased DNA methylation markers define an extensive field defect in histologically normal prostate tissues associated with prostate cancer: new biomarkers for men with prostate cancer202512,231,812Device interaction method and electronic device202512,187,328Guide-type anti-climbing energy-absorbing device based on hydraulic shearing202512,166,608Anti-interference method for new radio network202412,122,868Hydroxyl-terminated polybutadiene-based polyurethane (HTPB-PU)-modified asphalt and preparation method thereof202412,115,219Compositions and methods for inhibiting pathogen infection202412,071,672Unbiased DNA methylation markers define an extensive field defect in histologically normal prostate tissues associated with prostate cancer: new biomarkers for men with prostate cancer202411,918,228Left atrial appendage occluder202411,897,939Compositions and methods for inhibiting pathogen infection202411,856,507Network search and configuring method, registration method, device and system202311,721,021Image analysis of epithelial component of histologically normal prostate biopsies predicts the presence of cancer2023D0983770Speaker202311,535,921Method and device for controlling flow of liquid zinc in zinc pot for hot-dip galvanization202211,463,812Stereo microphone speaker202211,449,987Image analysis of epithelial component of histologically normal prostate biopsies predicts the presence of cancer202211,413,609Photocatalytic oil-water separation material and preparation method thereof202211,401,410Block copolymer compositions, prepregs, and laminates made therefrom202211,377,694Unbiased DNA methylation markers define an extensive field defect in histologically normal prostate tissues associated with prostate cancer: new biomarkers for men with prostate cancer202211,246,913Suspension formulation comprising an insulinotropic peptide2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to WISCONSIN ALUMNI RES FOUND (5)· patent assignee history
2022–2023Patents assigned to MEDICAL COLLEGE WISCONSIN INC (2)· patent assignee history
2022Patents assigned to BAOSHAN IRON & STEEL (1)· patent assignee history
2022–2025Based in CN· patent location history
2022–2025Based in US· patent location history
2024–2025Patents assigned to HUAWEI TECH CO LTD (4)· patent assignee history
2024Patents assigned to UNIV NORTH CAROLINA CHAPEL HILL (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WISCONSIN ALUMNI RES FOUND | 5 | 2022–2025 |
| HUAWEI TECH CO LTD | 4 | 2024–2025 |
| MEDICAL COLLEGE WISCONSIN INC | 2 | 2022–2023 |
| UNIV NORTH CAROLINA CHAPEL HILL | 2 | 2024 |
| BAOSHAN IRON & STEEL | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 14 | 2022–2025 |
| US | 10 | 2022–2025 |